Bribery Act Statement
The Bribery Act 2010 which came into force on 1 July 2011 aims to tackle bribery and corruption in both the public and private sectors.
Bribery can be defined as “giving someone a financial or other advantage to encourage them to perform their functions or activities improperly or reward them for having done so”.
Alturix is committed to applying the highest standards of ethical conduct, following good business practice, and having robust controls in place to prevent bribery. As an organisation we cannot afford to be complacent and under no circumstances is the giving, offering, receiving or soliciting of a bribe acceptable. It is essential that everyone working for, or on behalf of, Alturix is not only aware of the standards of behaviour expected of them, but is also aware of their personal responsibilities in relation to the prevention of bribery and corruption.
Modern Slavery Act Statement
Alturix is publishing this statement under the provision of the UK Modern Slavery Act 2015 (the ‘Act’). The Act requires business to state the actions they have taken during the financial year to ensure modern slavery is not taking place in their operations and supply chains.
Modern slavery is ‘a hidden crime that encompasses slavery, servitude, forced labour and human tracking’. Modern slavery has no place in our business or supply chain and we take a zero tolerance approach to it. Even with a relatively focused supply chain, we remain strongly committed to playing our part in eradicating modern slavery and recognise the importance of transparency in driving collaborative action and the potential impact of the Act on reducing risks and incidence of slavery. We encourage similar attitudes with all our suppliers, and review their policies and procedures before accepting them into our supply chain.
Data Protection Act Statement
ALTURiX Limited regards the lawful and appropriate treatment of personal information as very important to its successful operations and essential to maintaining confidence between the company and those with whom it carries out business. ALTURiX therefore fully endorses and adheres to the Principles of the General Data Protection Regulation 2016 as supplemented by the Data Protection Act 2018, and any other national laws which relate to the processing of personal data.
The relationship between the pharmaceutical industry and healthcare professionals, and healthcare organisations, plays a vital role in the development and delivery of life-enhancing and life-saving medicines.
At the core of the relationship is sharing knowledge to improve outcomes for patients.
We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why, as part of a Europe-wide initiative, the UK pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to healthcare professionals, and healthcare organisations.
Alturix fully supports this approach, and publishes this information on the Disclosure UK database.
For 2019, this information was recorded under Atlantic Pharma. From 2020 onwards, this is recorded under Alturix.